Arkolith/Insider Trading/IGC/Form 4

Grimaldi Claudia

DirectorIGC Pharma, Inc. (IGC) · full profile →Form 4 · filed Mar 15, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
4 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2024Option exercise(M)83K—$0784K
Mar 13, 2024Option exercise(M)95K—$01.0M
Mar 13, 2024Option exercise(M)100K—$0942K
Mar 13, 2024Option exercise(M)58K—$0842K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2024Grant(A)550K—$0550K
Mar 13, 2024Grant(A)360K—$0360K
Mar 13, 2024Option exercise(M)95K—$0285K
Mar 13, 2024Option exercise(M)100K—$0200K
Mar 13, 2024Option exercise(M)58K—$058K
Mar 13, 2024Option exercise(M)83K—$00

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001185185-24-000264) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for IGC Pharma, Inc.

Build

Ask your agent about IGC insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001185185-24-000264"
Ask your agent
Use Arkolith to summarize insider buying and selling at IGC Pharma, Inc.
over the last 90 days and cite the filings.